Skip to main content
. 2018 Jul 27;3(2):102–123. doi: 10.1002/btm2.10096

Table 4.

FDA recommended initial regimens of CART20

Preferred INSTI + 2 NRTIs
 regimens Dolutegravir, Abacavir, Lamivudine
Dolutegravir, Tenofovir, Emtricitabine
Elvitegravir, Cobicistat, Tenofovir, Emtricitabine
Raltegravir, Tenofovir, Emtricitabine
Recommended in certain situations Boosted PI (either Cobicistat or Ritonavir) + 2 NRTIs
Darunavir or Atazanavir, Tenofovir, Emtricitabine
Darunavir or Atazanavir, Abacavir, Lamivudine
NNRTI + 2 NRTIs
Efavirenz or Rilpivirine, Tenofovir, Emtricitabine
INSTI + 2 NRTIs
Raltegravir, Abacavir, Lamivudine
Regimens if Abacavir and Tenofovir cannot be used
Darunavir, Raltegravir
Lopinavir, Lamivudine